Ekso Bionics Holdings, Inc. (EKSO)
Company Description
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally.
It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.
The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.
The company also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therap, an adjustable and lower-limb powered exoskeleton; and Ekso Indego Personal, a powered lower limb orthosis.
It has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in San Rafael, California.
Country | United States |
Founded | 2005 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
Employees | 72 |
CEO | Scott G. Davis |
Contact Details
Address: 101 Glacier Point, Suite A San Rafael, California 94901 United States | |
Phone | 510-984-1761 |
Website | eksobionics.com |
Stock Details
Ticker Symbol | EKSO |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001549084 |
CUSIP Number | 282644301 |
ISIN Number | US2826443010 |
SIC Code | 3569 |
Key Executives
Name | Position |
---|---|
Scott G. Davis | Chief Executive Officer and Director |
Jerome Wong | Corporate Controller, Corp. Secretary and Chief Financial Officer |
Rachael Anderson | Global Director of Marketing and Strategic Growth |
Anthony Pratt | Vice President of Sales |
Ann Cookson | HR Director |
Foon Lim Chwee | President of APAC |
Jason C. Jones | Senior Vice President of Product Development |
Stephan Aderhold | Senior Vice President and GM of EMEA |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 14, 2023 | 8-K | Current Report |
Oct 26, 2023 | 10-Q | Quarterly Report |
Oct 26, 2023 | 8-K | Current Report |
Sep 29, 2023 | 8-K | Current Report |
Aug 18, 2023 | 8-K | Current Report |
Jul 28, 2023 | 8-K | Current Report |
Jul 28, 2023 | 424B5 | Filing |
Jul 27, 2023 | 10-Q | Quarterly Report |
Jul 27, 2023 | 8-K | Current Report |
Jun 20, 2023 | EFFECT | Notice of Effectiveness |